Security key
74449F118
PSYENCE BIOMEDICAL LTD. - *W EXP 01/22/202 (PBMWW)
CUSIP: 74449F118
Q1 2026 13F Holders as of 31 Mar 2026
- Security type / class
- Equity / *W EXP 01/22/202
- Total 13F shares
- 5,261,099
- Total 13F value
- $95,646
- Share change
- -205,318
- SEC-reported price per share
- $0.02
- Number of holders
- 18
- Value change
- -$4,026
- Number of buys
- 1
- Number of sells
- 3
Report period
Q1 2026
Institutions
18
Top holders
10
PBMWW full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2026
PSYENCE BIOMEDICAL LTD. SEC filings
PSYENCE BIOMEDICAL LTD. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 74449F118
Recent filing periods:
Ownership snapshot
Top reported holders of PBMWW - PSYENCE BIOMEDICAL LTD. - *W EXP 01/22/202 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Psyence Labs Ltd
Disclosed value leader
Psyence Labs Ltd
Comparable rows
5/15
Latest evidence
25 Feb 2026
13D/G
13F
Lead comparable stake: 30%
10 rows are not safely comparable across share classes.
13D/G row: Psyence Labs Ltd
Showing 1-6 of 15 holder rows.
Quick read
Psyence Labs Ltd leads the comparable SEC ownership view at 30%.
5 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Psyence Labs Ltd's linked filing trail.
Comparable ownership
Top 5
Psyence Labs Ltd
30%
Hudson Bay Capital Management LP
5%
Kaos Capital Ltd
4.9%
Weiner Jeffrey David
2.6%
AdvisorShares Trust
0.79%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Psyence Labs Ltd |
13D/G
|
30%
Reported 13D/G
· 25 Feb 2026
|
$825,234
1,146,159 shares
|
$0 | 25 Feb 2026 |
| Hudson Bay Capital Management LP |
13D/G
|
5%
Reported 13D/G
· 31 Mar 2025
|
$133,150
237,768 shares
|
-$79,650 | 31 Mar 2025 |
| Kaos Capital Ltd |
13D/G
|
4.9%
Reported 13D/G
· 08 Jan 2026
|
$236,098
313,876 shares
|
$0 | 08 Jan 2026 |
| Weiner Jeffrey David |
13D/G
|
2.6%
Reported 13D/G
· 25 Feb 2026
|
$43,020
59,750 shares
|
+$5,688 | 25 Feb 2026 |
| AdvisorShares Trust |
13D/G
|
0.79%
Reported 13D/G
· 31 Dec 2024
|
$15,077
26,924 shares
|
$0 | 31 Dec 2024 |
| Parallel Advisors, LLC |
13F
Company
|
—
mixed-class rows
|
$687,185
178,750 shares
mixed-class rows
|
— | 31 Dec 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
18
Shares
5,261,099
Rows available
18
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2026 vs Q1 2026 Across Filers
Q1 2026 holders
18
Q1 2026 holders
18
Holder diff
0
| Investor | Q1 2026 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q1 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend